ACM
AZN icon

Altrius Capital Management’s AstraZeneca AZN Stock Holding History

Altrius Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Sell
55,528
-2,004
-3% -$386K 2.18% 5
2025
Q4 		$10.6M Sell
57,532
-2,248
-4% -$394K 2.24% 3
2025
Q3 		$9.17M Buy
59,780
+769
+1% +$116K 2.09% 7
2025
Q2 		$8.25M Buy
59,011
+184
+0.3% +$25.8K 1.93% 19
2025
Q1 		$8.65M Buy
58,827
+1,250
+2% +$181K 2.1% 9
2024
Q4 		$7.54M Buy
57,577
+3,182
+6% +$445K 2.03% 11
2024
Q3 		$8.48M Sell
54,395
-1,712
-3% -$276K 2.12% 9
2024
Q2 		$8.75M Sell
56,107
-263
-0.5% -$39.6K 2.3% 2
2024
Q1 		$7.64M Buy
56,370
+6,511
+13% +$862K 1.93% 15
2023
Q4 		$6.72M Buy
49,859
+817
+2% +$106K 1.87% 15
2023
Q3 		$6.64M Buy
49,042
+613
+1% +$83.7K 1.97% 13
2023
Q2 		$6.93M Sell
48,429
-153
-0.3% -$22.5K 2.05% 11
2023
Q1 		$6.74M Buy
48,582
+902
+2% +$121K 2.06% 12
2022
Q4 		$6.47M Buy
47,680
+710
+2% +$89K 2.03% 7
2022
Q3 		$5.15M Buy
46,970
+7,074
+18% +$897K 1.96% 3
2022
Q2 		$5.27M Buy
+39,896
New +$5.23M 1.71% 6

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Altrius Capital Management's AZN Position: Q1 2026 in Review

Altrius Capital Management reduced its AstraZeneca (AZN) stake by 3.5% in Q1 2026, selling an estimated $386K and leaving 55,528 shares worth $11M. The position accounts for 2.18% of the portfolio, ranked #5.

Altrius Capital Management first reported a position in AZN in Q2 2022 and has held it in 16 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Altrius Capital Management held 55,528 shares of AstraZeneca worth $11M as of Q1 2026.
  • Altrius Capital Management sold 2,004 AstraZeneca shares in Q1 2026, an estimated $386K.
  • AstraZeneca made up 2.18% of Altrius Capital Management's portfolio in Q1 2026, its #5 holding.
  • Altrius Capital Management first reported a position in AstraZeneca in Q2 2022 and has held it in 16 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Altrius Capital Management's 13F filing for Q1 2026, filed 5 May 2026.